The effect and mechanism of Zishen Yutai Pill on IVF-ET in patients with diminished ovarian reserve

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100048441

Enrollment

Unknown

Registered

2021-07-07

Start date

2020-01-01

Completion date

Unknown

Last updated

2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IVF-ET in patients with diminished ovarian reserve

Interventions

treatment group:Zishen Yutai Pills (ZYP)

control group :Conventional treatment

Eligibility

Sex/Gender

Female

Age

22 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. <=40 years old; 2. woman with any of the risk factors for POR and/or an abnormal ovarian reserve test (i.e., antral follicular count (AFC) <5–7 follicles or AMH <0.5–1.1 ng/ml).

Exclusion criteria

Exclusion criteria: 1. Endometriosis, Polycystic ovary syndrome; 2. Cardiovascular, cerebrovascular, liver, kidney and hematopoietic system, and mental illness; 3. Received hormone drug therapy within half a year; 4. Allergic to the drug used in this study; 5. Taken other traditional Chinese medicine.

Design outcomes

Primary

Measure	Time frame
pregnancy outcome;	—

Countries

China

Contacts

Public ContactXiufang Li

Reproductive Hospital Affiliated to Shandong University

xiufang-82@163.com+86 18668952218

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026